Post-Traumatic Stress Disorder Clinical Trial
Official title:
Treatment of PTSD in Recently Battered Women Living in Shelters
This study will evaluate the effectiveness of a brief cognitive behavioral treatment, Helping to Overcome PTSD through Empowerment, in treating abused women with post-traumatic stress disorder who are living in shelters.
Intimate partner violence is a serious social problem with potentially severe mental health
and functional consequences consistent with post-traumatic stress disorder (PTSD). Shelters
provide an important resource for abused women in that they offer emergency shelter,
support, and access to community resources that can aid in establishing long-term safety for
women and their children. However, recent research suggests that symptoms of PTSD can
compromise abused women's ability to access and effectively use these resources, emphasizing
the importance of initiating treatment for PTSD. Despite the fact that on an annual basis
300,000 battered women and children access shelter services, virtually no research has
investigated treatment of PTSD in sheltered abused women. A woman's entry into a shelter
seems to be a prime time to begin any necessary psychological treatment. Helping to Overcome
PTSD through Empowerment (HOPE), a brief cognitive behavioral treatment that emphasizes
stabilization and empowerment of women, may help in treating abused women with PTSD. This
study will evaluate the effectiveness of HOPE in treating abused women with PTSD who are in
shelters.
Participation in this single-blind study will begin during a woman's shelter stay and will
end 8 months after she completes the shelter treatment period. All potential participants
will first undergo an initial interview, which will include questions about their abusive
relationships, emotional difficulties, stressful events, and other previous treatments.
Participants invited to continue with the study will be randomly assigned to the HOPE
program or to shelter treatment as usual. Participants assigned to the HOPE program will
participate in a maximum of 16 counseling sessions, with up to 10 of these sessions taking
place while they are at the shelter. During these sessions, participants will learn skills
to help manage emotional difficulties and ways to deal with their abusive relationships.
Participants will attend two 60- to 90-minute sessions each week until they complete of the
10 shelter-based counseling sessions or depart from the shelter. Counseling sessions will
continue at St. Thomas Hospital or other agreed-upon location twice per week during the
first 8 weeks after departure from the shelter. All participants will repeat the initial
interview and/or questionnaire at various times during and after the shelter stay, for a
total of eight assessments. The final interview assessment will occur 6 months after
participants complete the counseling sessions.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04317820 -
Deep Brain Reorienting in Post-traumatic Stress Disorder
|
N/A | |
Completed |
NCT05112003 -
Translingual Neurostimulation for the Virtual Treatment of Post-Traumatic Stress Disorder: A Feasibility Pilot
|
N/A | |
Recruiting |
NCT04518267 -
Anger and Psychotrauma: Data From Military and Civilians
|
||
Completed |
NCT02502604 -
Cognitive Training Program for Individuals With Depression and Post-Traumatic Stress Disorder
|
N/A | |
Terminated |
NCT02234687 -
A mGlu2/3 Agonist in the Treatment of PTSD
|
Phase 1 | |
Completed |
NCT02256566 -
Cognitive Training for Mood and Anxiety Disorders
|
N/A | |
Completed |
NCT01738308 -
The Effects of Healing Touch on Post Operative Pediatric Patients
|
N/A | |
Terminated |
NCT02520726 -
PTSD Prevention Study Examining the Efficacy of Sertraline in Burn Victims
|
Phase 4 | |
Completed |
NCT02213900 -
Preventing Post-Operative Delirium in Patients Undergoing a Pneumonectomy, Esophagectomy or Thoracotomy
|
Phase 4 | |
Completed |
NCT01517711 -
Tramadol Extended-Release (ER) for Posttraumatic Stress Disorder (PTSD)
|
Phase 4 | |
Completed |
NCT01437891 -
Sentra AM® and Sentra PM® for Post-traumatic Stress Disorder (PTSD) and Gulf War Fibromyalgia (GWF)
|
N/A | |
Completed |
NCT01998100 -
Maximizing Treatment Outcome in Post-Traumatic Stress Disorder (PTSD)
|
Phase 3 | |
Completed |
NCT01199107 -
Maximizing Treatment Outcome and Examining Sleep in Post-traumatic Stress Disorder (PTSD)
|
Phase 3 | |
Completed |
NCT01231711 -
Improving Quality-of-life and Depressive Symptoms of Combat Veterans Via Internet-based Intervention
|
Phase 1 | |
Completed |
NCT00348036 -
Group Intervention for Interpersonal Trauma
|
N/A | |
Completed |
NCT00680524 -
Telephone-based Care for OEF/OIF Veterans With PTSD
|
N/A | |
Completed |
NCT00838006 -
Psychophysiologic Predictors of Post-deployment Mental Health Outcomes
|
N/A | |
Completed |
NCT00525226 -
Evaluating the Effects of Stress in Pregnancy
|
N/A | |
Completed |
NCT00183690 -
Prolonged Exposure Therapy Versus Active Psychotherapy in Treating Post-Traumatic Stress Disorder in Adolescents
|
Phase 1 | |
Completed |
NCT00127673 -
Comparison of Two Treatments for Post-Traumatic Stress Disorder
|
Phase 3 |